Institutional Ownership
Cardiff Oncology Inc
CUSIP 14147L108COMCRDFQ1 2026
13D / 13G Filings
34
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
11.0%
Max % of class reported
Institutional Holders
111
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
34 filings · latest Aug 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Aug 14, 2025 | Commodore Capital LP | 13G/A | 11.0% | 9 | SEC |
| 2 | Jul 29, 2025 | The Vanguard Group | 13G | 5.6% | 3.73M | SEC |
| 3 | Apr 23, 2025 | Blackrock, Inc. | 13G | 5.8% | 3.84M | SEC |
| 4 | Feb 12, 2025 | Pfizer Inc. 13-5315170 | 13G/A | 3.6% | 2.41M | SEC |
| 5 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 4.3% | 2.84M | SEC |
| 6 | Dec 17, 2024 | Commodore Capital LP | 13G | 8.1% | 5.38M | SEC |
| 7 | Nov 8, 2024 | Blackrock, Inc. | 13G | 5.9% | 2.74M | SEC |
| 8 | Oct 24, 2024 | Blackrock, Inc. | 13G | 5.9% | 2.74M | SEC |
| 9 | Feb 6, 2024 | Acorn Bioventures, L.P. | 13G/A | 4.2% | 1.95M | SEC |
| 10 | Feb 14, 2023 | Caxton Corp | 13G/A | 2.2% | 983.6K | SEC |
24 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Cardiff Oncology Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 3.98M | $6.45M |
| 2 | Laurion Capital Management LP | 2.65M | $4.29M |
| 3 | Pfizer Inc | 2.41M | $3.74M |
| 4 | Acorn Capital Advisors, LLC | 1.76M | $2.85M |
| 5 | Geode Capital Management, LLC | 1.60M | $2.59M |
| 6 | Franklin Resources Inc | 1.21M | $1.95M |
| 7 | State Street Corp | 1.19M | $1.92M |
| 8 | Blair William & Co/Il | 922.4K | $1.49M |
| 9 | Flputnam Investment Management Co | 595.1K | $964.1K |
| 10 | Northern Trust Corp | 493.2K | $799.0K |